The JAK 2 V 617 F activating tyrosine kinase mutation is an infrequent event in both “ atypical ” myeloproliferative disorders and myelodysplastic syndromes
暂无分享,去创建一个
R. Levine | D. Gilliland | D. Steensma | H. Powell | G. Dewald | T. Lasho | R. McClure | R. Mcclure